Abstract
Belgium Wound Care Management Medical Equipment Industry Report
Summary
This report is an essential source for in-depth information and data relating
to Belgium wound care management medical equipment market. It also offers
detailed and comprehensive coverage of market revenue, volume, distribution
and company share information; and latest news, financial deals and pipeline
products information of each of the key sub-segments of thewound care
management in Belgium
Scope
・ The report provides sector information broken down into detailed categories
and segments in country.
・ Total revenues, products sold, end users, and
average pricing.
・ Market shares of all the key competitors.
・ Key
pipeline products that are set to shape the market, broken down by sector.
・ Information on the top medical equipment companies in the sector in the
country covering business description, strategic analysis, and financial
information.
・ Healthcare structure, regulatory environment, approval
process, pricing trends and reimbursement.
・ Product and brand updates,
strategy changes, R&D projects, corporate expansions and contractions and
regulatory changes.
・ Key mergers and acquisitions, partnerships, private
equity investments and IPOs.
・ Customer, hospitals and physicians
data.
Reasons to buy
・ Gain a strong understanding of the industry at a global level, with break
downs for the country
・ Evaluate and compare the attractiveness of the
market in the country.
・ Identify growth segments and opportunities in
each industry sector within the country.
・ Evaluate the pipeline of key
products that will change the sector, and identify threats and opportunities
before the products are launched in the country.
・ Analyze the
competitiveness of the market in the country and identify hotspots.
・
Develop strategies based on the latest product, brand, expansion and research
and development news in the country.
・ Do deals with an understanding of
how competitors are financed, and the mergers and partnerships that have
shaped the market in the country.
・ Identify and analyze the strengths and
weaknesses of the industry incumbents in the country.
Table of Contents
Table of Contents
1 Table Of Contents 2
1.1 List Of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What Is This Report
About? 16
2.2 Definitions 16
2.2.1 Wound Care Management 16
3
Healthcare Sector Review 18
3.1 Healthcare Expenditure 18
3.2
Healthcare Infrastructure 20
3.2.1 Healthcare Personnel Data 21
3.2.2
Healthcare Facilities Data 22
3.3 Healthcare Policy 23
4 Wound Care
Management in Belgium 25
4.1 Wound Care Management Overall Revenues
(2000-2012) 25
4.2 Wound Care Management Overall Volume (2000-2012) 31
4.3 Wound Care Management Overall Company Shares (2005-2006) 34
5 Wound
Closure Devices in Belgium 35
5.1 Wound Closure Devices Overall Revenues
(2000-2012) 35
5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
39
5.1.2 Hemostats Overall Revenues (2000-2012) 41
5.1.3 Tissue
Sealants Overall Revenues (2000-2012) 43
5.2 Wound Closure Devices Overall
Volume (2000-2012) 45
5.2.1 Skin Closure Devices Overall Volume
(2000-2012) 47
5.2.2 Tissue Sealants Overall Volume (2000-2012) 49
5.2.3 Hemostats Overall Volume (2000-2012) 51
5.3 Wound Closure Devices
Average Price (2000-2012) 53
5.3.1 Hemostats Average Price (2000-2012)
53
5.3.2 Tissue Sealants Average Price (2000-2012) 55
5.3.3 Skin
Closure Devices Average Price (2000-2012) 57
5.4 Wound Closure Devices
Distribution Share (2005-2006) 59
5.5 Wound Closure Devices Company Share
(2005-2006) 60
6 Ostomy in Belgium 61
6.1 Ostomy Overall Revenue
(2000-2012) 61
6.2 Ostomy Overall Volume (2000-2012) 63
6.3 Ostomy
Average Price (2000-2012) 65
6.4 Ostomy Distribution Share (2005-2006)
67
6.5 Ostomy Company Share (2005-2006) 68
7 Advanced Wound Management
in Belgium 69
7.1 Advanced Wound Management Overall Revenue (2000-2012)
69
7.2 Advanced Wound Management Overall Volume (2000-2012) 71
7.3
Advanced Wound Management Average Price (2000-2012) 73
7.4 Advanced Wound
Management Distribution Share (2005-2006) 75
7.5 Advanced Wound Management
Company Share (2005-2006) 76
8 Traditional Wound Management 77
8.1
Traditional Wound Management Overall Revenue (2000-2012) 77
8.2
Traditional Wound Management Overall Volume (2000-2012) 79
8.3 Traditional
Wound Management Average Price (2000-2012) 81
8.4 Traditional Wound
Management Distribution Share (2005-2006) 83
8.5 Traditional Wound
Management Company Share (2005-2006) 84
9 Compression Therapy in Belgium
85
9.1 Compression Therapy Overall Revenue (2000-2012) 85
9.2
Compression Therapy Overall Volume (2000-2012) 87
9.3 Compression Therapy
Average Price (2000-2012) 89
9.4 Compression Therapy Distribution Share
(2005-2006) 91
9.5 Compression Therapy Company Share (2005-2006) 92
10
Baxter International Company Profile 93
10.1 Company Overview 93
10.2
Business Overview 93
10.2.1 BioScience 93
10.2.2 Medication Delivery
93
10.2.3 Renal 94
10.2.4 Products 94
10.2.5 History 95
10.3
Value Chain Analysis 98
10.3.1 Manufacturing 98
10.3.2 Product
Development 99
10.3.3 Sales and Marketing 100
10.4 SWOT Analysis
101
10.4.1 Baxter International Inc. Strengths 101
10.4.2 Baxter
International Inc. Weaknesses 102
10.4.3 Baxter International Inc.
Opportunities 102
10.4.4 Baxter International Inc. Threats 103
10.5
Financial and Operational Review 104
10.6 Locations And Subsidiaries
105
10.7 Financial Deals Landscape 108
10.7.1 Baiyunshan And Baxter
Form A Joint Venture In China 108
10.7.2 Baxter Signs Licensing Agreement
With Intercytex And Spinal Restoration 109
10.7.3 Baxter Sells Transfusion
Therapies Business to Texas Pacific and Maverick Capital 111
10.7.4 B.
Braun Acquires Renal Therapy Business Of Baxter 113
10.7.5 Innovata signs
a license agreement with Baxter International 115
10.7.6 Kuros Biosurgery
Signs An Agreement With Baxter International 116
10.7.7 Gambro Signs An
Agreement With Baxter 118
10.7.8 Baxter Healthcare And Gambro Enter Into
An Agreement 119
10.7.9 Baxter and Cerus Enter Into Agreement With BioOne
for Commercialization Of INTERCEPT Blood System 121
10.7.10 Baxter
International And Kaketsuken Enter Into Agreement 123
10.7.11 Baxter To
Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful 124
10.8
Recent Developments 125
10.8.1 Jan 24, 2008: Baxter Achieves Record Sales
and Earnings for Full-Year 2007 125
10.8.2 Dec 18, 2007: Baxter Elects CFO
127
10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend 128
10.8.4
Aug 01, 2007: Baxter Elects New Board Director 128
10.8.5 Jul 31, 2007:
Baxter Announces Quarterly Dividend 128
10.8.6 Mar 13, 2007: Baxter
Declares Additional Share Repurchase Authorization 128
10.8.7 Feb 13,
2007: Baxter Announces Quarterly Dividend 129
10.8.8 Nov 28, 2006: Baxter
Announces Annual Dividend 129
10.8.9 Sep 14, 2006: Baxter Appoints
President, Baxter Latin America 129
10.9 Baxter International Inc.
Pipeline Products 130
10.9.1 Next-Generation Home Hemodialysis Machine
130
11 The HARTMANN GROUP Company Profile 132
11.1 Company Overview
132
11.2 Business Overview 132
11.2.1 Incontinence Management 132
11.2.2 Operating Theater Management 132
11.2.3 Other GROUP Activities
133
11.2.4 Wound Management 133
11.2.5 Products 133
11.2.6 History
134
11.3 Value Chain Analysis 136
11.3.1 Manufacturing 136
11.3.2
Product Development 137
11.3.3 Sales and Marketing 137
11.4 SWOT
Analysis 137
11.4.1 HARTMANN GROUP Strengths 138
11.4.2 HARTMANN GROUP
Weaknesses 138
11.4.3 HARTMANN GROUP Opportunities 139
11.4.4 HARTMANN
GROUP Threats 139
11.5 Financial and Operational Review 141
11.6
Locations And Subsidiaries 142
11.7 Recent Developments 144
11.7.1 Mar
17, 2008: Hartmann Declares 2007 Results 144
11.7.2 Jan 29, 2008: HARTMANN
Establishes New Subsidiary In Siberia 145
11.7.3 Jan 11, 2008: HARTMANN
Launches New Subsidiary In Ulm 146
11.7.4 Aug 10, 2007: Hartmann Reports
H1 2007 Results 146
12 Coloplast A/S Company Profile 149
12.1 Company
Overview 149
12.2 Business Overview 149
12.2.1 Medical Care 149
12.2.2 Major Products and Services 150
12.2.3 History 150
12.3 Value
Chain Analysis 152
12.3.1 Manufacturing 152
12.3.2 Product Development
153
12.3.3 Sales and Marketing 154
12.4 SWOT Analysis 155
12.4.1
Coloplast A/S Strengths 155
12.4.2 Coloplast A/S Weaknesses 156
12.4.3
Coloplast A/S Opportunities 156
12.4.4 Coloplast A/S Threats 157
12.5
Financial and Operational Review 159
12.5.1 Financial Statements 159
12.5.2 Financial Ratios 160
12.5.3 Share Holding Structure 160
12.6
Locations And Subsidiaries 161
12.7 Financial Deals Landscape 163
12.7.1 Coloplast Sells Brachytherapy Business To Core Oncology 163
12.7.2
Coloplast Signs Distribution Agreement With Carbon Medical Technologies
164
12.7.3 Granville Baird Capital Partners Advisors Acquires Coloplast' s
Business Unit 166
12.7.4 McKesson Corporation Acquires Sterling Medical
Services 167
12.7.5 Coloplast Acquires Surgical Urology And Clinical And
Consumer Healthcare Business Segments Of Mentor 169
12.8 Recent
Developments 171
12.8.1 Apr 07, 2008: Coloplast Plans To Invest EUR100
Million In Hungary 171
12.8.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal
2008 Results 171
12.8.3 Nov 20, 2007: Coloplast Declares Fiscal 2007
Results 173
12.8.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007
Results 175
12.8.5 May 15, 2007: Colplast Declares H1 2007 Results 176
12.8.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results 178
12.8.7
Dec 13, 2006: Coloplast Appoints New Chairman 179
12.8.8 Nov 15, 2006:
Coloplast Declares Fiscal 2006 Results 179
13 ConvaTec Company Profile
181
13.1 Company Overview 181
13.2 Business Overview 181
13.2.1
Major Products and Services 181
13.2.2 History 182
13.3 Locations And
Subsidiaries 183
13.4 Recent Developments 184
13.4.1 Jan 22, 2008:
Vivolution Acquires Patent From BMS 184
13.4.2 Nov 12, 2007: Alltracel
Signs Development Agreement With ConvaTec 184
14 Ethicon, Inc. Company
Profile 185
14.1 Company Overview 185
14.2 Business Overview 185
14.2.1 Products 186
14.3 Locations And Subsidiaries 186
14.4 Financial
Deals Landscape 188
14.4.1 Edwards Lifesciences Acquires CardioVations
Product Line From ETHICON 188
14.4.2 Musculoskeletal Transplant Signs
Marketing Agreement With ETHICON 190
14.4.3 ETHICON Acquires Vascular
Control Systems 191
14.4.4 Datascope Acquires Endoscopic Vessel Harvesting
Business From ETHICON 192
15 Regulation System 195
15.1 Medical
Equipment Approval Process 195
15.1.1 Classification 196
15.1.2
Conformity Assessment Process 205
15.2 Notification Fee 209
16 Pricing
and Reimbursement 210
16.1 Reimbursement Policies 210
17 Distribution
Structure 211
18 APPENDIX 212
18.1 Global Markets Direct Research
Methodology 212
18.2 Coverage 213
18.3 Secondary Research 213
18.4
Primary Research 214
18.5 Models 214
18.6 Forecasts 215
18.7
Expert Panels 215
18.8 Currency Conversion 216
18.9 Contact Us 217
18.10 Disclaimer 217
List of Tables
1.1 List Of
Tables
Table 1: Hospitals and Hospital Beds in Belgium, 2005 20
Table
2: Number of Doctors by Specialty in Belgium, 2003-2007 21
Table 3: Number
of Hospital Wards by Specialty in Belgium, 2003-2007 22
Table 4: Wound
Care Management, Belgium, Overall Revenues ($ mn), 2000-2012 25
Table 5:
Wound Care Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
26
Table 6: Wound Care Management, Belgium, Overall Revenues ($ mn),
Forecast, 2007-2012 27
Table 7: Wound Care Management, Belgium, Category
Revenues ($ mn), 2000-2012 28
Table 8: Wound Care Management, Belgium,
Category Revenues ($ mn), Historic, 2000-2007 29
Table 9: Wound Care
Management, Belgium, Category Revenues ($ mn), Forecast, 2007-2012 30
Table 10: Wound Care Management, Belgium, Category Volume (Units), 2000-2012
31
Table 11: Wound Care Management, Belgium, Category Volume (Units),
Historic, 2000-2007 32
Table 12: Wound Care Management, Belgium, Category
Volume (Units), Forecast, 2007-2012 33
Table 13: Wound Care Management,
Belgium, Company Share by Revenue ($ mn), 2005-2006 34
Table 14: Wound
Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007 35
Table 15: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Forecast,
2007-2012 36
Table 16: Wound Closure Devices, Belgium, Revenue by Segment
($ mn), Historic, 2000-2007 37
Table 17: Wound Closure Devices, Belgium,
Revenue by Segment ($ mn), Forecast, 2007-2012 38
Table 18: Skin Closure
Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007 39
Table
19: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Forecast,
2007-2012 40
Table 20: Hemostats, Belgium, Overall Revenues ($ mn),
Historic, 2000-2007 41
Table 21: Hemostats, Belgium, Overall Revenues ($
mn), Forecast, 2007-2012 42
Table 22: Tissue Sealants, Belgium, Overall
Revenues ($ mn), Historic, 2000-2007 43
Table 23: Tissue Sealants,
Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 44
Table 24: Wound
Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007 45
Table 25: Wound Closure Devices, Belgium, Overall Volume (Units), Forecast,
2007-2012 46
Table 26: Skin Closure Devices, Belgium, Overall Volume
(Units), Historic, 2000-2007 47
Table 27: Skin Closure Devices, Belgium,
Overall Volume (Units), Forecast, 2007-2012 48
Table 28: Tissue Sealants,
Belgium, Overall Volume (Units), Historic, 2000-2007 49
Table 29: Tissue
Sealants, Belgium, Overall Volume (Units), Forecast, 2007-2012 50
Table
30: Hemostats, Belgium, Overall Volume (Units), Historic, 2000-2007 51
Table 31: Hemostats, Belgium, Overall Volume (Units), Forecast, 2007-2012
52
Table 32: Hemostats, Belgium, Average Price ($), Historic, 2000-2007
53
Table 33: Hemostats, Belgium, Average Price ($), Forecast, 2007-2012
54
Table 34: Tissue Sealants, Belgium, Average Price ($), Historic,
2000-2007 55
Table 35: Tissue Sealants, Belgium, Average Price ($),
Forecast, 2007-2012 56
Table 36: Skin Closure Devices, Belgium, Average
Price ($), Historic, 2000-2007 57
Table 37: Skin Closure Devices, Belgium,
Average Price ($), Forecast, 2007-2012 58
Table 38: Wound Closure Devices,
Belgium, Distribution Share by Revenue ($ mn), 2005-2006 59
Table 39:
Wound Closure Devices, Belgium, Company Share by Revenue ($ mn), 2005-2006
60
Table 40: Ostomy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
61
Table 41: Ostomy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
62
Table 42: Ostomy, Belgium, Overall Volume (Units), Historic, 2000-2007
63
Table 43: Ostomy, Belgium, Overall Volume (Units), Forecast, 2007-2012
64
Table 44: Ostomy, Belgium, Average Price ($), Historic, 2000-2007
65
Table 45: Ostomy, Belgium, Average Price ($), Forecast, 2007-2012
66
Table 46: Ostomy, Belgium, Distribution Share by Revenue ($ mn),
2005-2006 67
Table 47: Ostomy, Belgium, Company Share by Revenue ($ mn),
2005-2006 68
Table 48: Advanced Wound Management, Belgium, Overall
Revenues ($ mn), Historic, 2000-2007 69
Table 49: Advanced Wound
Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 70
Table
50: Advanced Wound Management, Belgium, Overall Volume (Units), Historic,
2000-2007 71
Table 51: Advanced Wound Management, Belgium, Overall Volume
(Units), Forecast, 2007-2012 72
Table 52: Advanced Wound Management,
Belgium, Average Price ($), Historic, 2000-2007 73
Table 53: Advanced
Wound Management, Belgium, Average Price ($), Forecast, 2007-2012 74
Table
54: Advanced Wound Management, Belgium, Distribution Share by Revenue ($ mn),
2005-2006 75
Table 55: Advanced Wound Management, Belgium, Company Share
by Revenue ($ mn), 2005-2006 76
Table 56: Traditional Wound Management,
Belgium, Overall Revenues ($ mn), Historic, 2000-2007 77
Table 57:
Traditional Wound Management, Belgium, Overall Revenues ($ mn), Forecast,
2007-2012 78
Table 58: Traditional Wound Management, Belgium, Overall
Volume (Units), Historic, 2000-2007 79
Table 59: Traditional Wound
Management, Belgium, Overall Volume (Units), Forecast, 2007-2012 80
Table
60: Traditional Wound Management, Belgium, Average Price ($), Historic,
2000-2007 81
Table 61: Traditional Wound Management, Belgium, Average
Price ($), Forecast, 2007-2012 82
Table 62: Traditional Wound Management,
Belgium, Distribution Share by Revenue ($ mn), 2005-2006 83
Table 63:
Traditional Wound Management, Belgium, Company Share by Revenue ($ mn),
2005-2006 84
Table 64: Compression Therapy, Belgium, Overall Revenues ($
mn), Historic, 2000-2007 85
Table 65: Compression Therapy, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 86
Table 66: Compression
Therapy, Belgium, Overall Volume (Units), Historic, 2000-2007 87
Table 67:
Compression Therapy, Belgium, Overall Volume (Units), Forecast, 2007-2012
88
Table 68: Compression Therapy, Belgium, Average Price ($), Historic,
2000-2007 89
Table 69: Compression Therapy, Belgium, Average Price ($),
Forecast, 2007-2012 90
Table 70: Compression Therapy, Belgium,
Distribution Share by Revenue ($ mn), 2005-2006 91
Table 71: Compression
Therapy, Belgium, Company Share by Revenue ($ mn), 2005-2006 92
Table 72:
Baxter International Inc., SWOT Analysis, 2006 101
Table 73:
Baxter International Inc., Financial Statements, USD Million, 2002-2006
104
Table 74: Baxter International Inc., Financial Ratios, USD
Million, 2002-2006 105
Table 75: Baxter International Inc., Other
Locations 106
Table 76: Baxter International Inc., Subsidiaries
107
Table 77: HARTMANN GROUP, SWOT Analysis, 2006 137
Table 78:
HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006 141
Table 79: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006
142
Table 80: HARTMANN GROUP, Subsidiaries 143
Table 81:
Coloplast A/S, SWOT Analysis, 2007 155
Table 82: Coloplast A/S,
Financial Statements, DKK Million, 2003-2007 159
Table 83: Coloplast
A/S, Financial Ratios, DKK Million, 2003-2007 160
Table 84: Coloplast
A/S, Share Holding Structure 160
Table 85: Coloplast A/S, Other
Locations 161
Table 86: Coloplast A/S, Subsidiaries 161
Table 87:
Coloplast A/S, Subsidiaries(Contd.) 162
Table 88: ConvaTec,
Other Locations 183
Table 89: Ethicon, Inc., Other Locations 187
Table 90: Ethicon, Inc., Subsidiaries 187
Table 91: Medical Equipment
Notification Fee in Belgium, 2007 209
Table 92: Currency Conversion from
USD to Local Currency at 2007 Constant Rate 216
List of
Figures
1.1 List of Figures
Figure 1: Total Healthcare
Expenditure in Belgium, 2000 -- 2006 19
Figure 2: Structure of Healthcare
System in Belgium, 2007 24
Figure 3: Wound Care Management, Belgium,
Overall Revenues ($ mn), 2000-2012 25
Figure 4: Wound Care Management,
Belgium, Overall Revenues ($ mn), Historic, 2000-2007 26
Figure 5: Wound
Care Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 27
Figure 6: Wound Care Management, Belgium, Category Revenues ($ mn), 2000-2012
28
Figure 7: Wound Care Management, Belgium, Category Revenues ($ mn),
Historic, 2000-2007 29
Figure 8: Wound Care Management, Belgium, Category
Revenues ($ mn), Forecast, 2007-2012 30
Figure 9: Wound Care Management,
Belgium, Category Volume (Units), 2000-2012 31
Figure 10: Wound Care
Management, Belgium, Category Volume (Units), Historic, 2000-2007 32
Figure 11: Wound Care Management, Belgium, Category Volume (Units), Forecast,
2007-2012 33
Figure 12: Wound Care Management, Belgium, Company Share (%),
2006 34
Figure 13: Wound Closure Devices, Belgium, Overall Revenues ($
mn), Historic, 2000-2007 35
Figure 14: Wound Closure Devices, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 36
Figure 15: Wound Closure
Devices, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007 37
Figure
16: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Forecast,
2007-2012 38
Figure 17: Skin Closure Devices, Belgium, Overall Revenues ($
mn), Historic, 2000-2007 39
Figure 18: Skin Closure Devices, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 40
Figure 19: Hemostats,
Belgium, Overall Revenues ($ mn), Historic, 2000-2007 41
Figure 20:
Hemostats, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 42
Figure
21: Tissue Sealants, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
43
Figure 22: Tissue Sealants, Belgium, Overall Revenues ($ mn), Forecast,
2007-2012 44
Figure 23: Wound Closure Devices, Belgium, Overall Volume
(Units), Historic, 2000-2007 45
Figure 24: Wound Closure Devices, Belgium,
Overall Volume (Units), Forecast, 2007-2012 46
Figure 25: Skin Closure
Devices, Belgium, Overall Volume (Units), Historic, 2000-2007 47
Figure
26: Skin Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012
48
Figure 27: Tissue Sealants, Belgium, Overall Volume (Units), Historic,
2000-2007 49
Figure 28: Tissue Sealants, Belgium, Overall Volume (Units),
Forecast, 2007-2012 50
Figure 29: Hemostats, Belgium, Overall Volume
(Units), Historic, 2000-2007 51
Figure 30: Hemostats, Belgium, Overall
Volume (Units), Forecast, 2007-2012 52
Figure 31: Hemostats, Belgium,
Average Price ($), Historic, 2000-2007 53
Figure 32: Hemostats, Belgium,
Average Price ($), Forecast, 2007-2012 54
Figure 33: Tissue Sealants,
Belgium, Average Price ($), Historic, 2000-2007 55
Figure 34: Tissue
Sealants, Belgium, Average Price ($), Forecast, 2007-2012 56
Figure 35:
Skin Closure Devices, Belgium, Average Price ($), Historic, 2000-2007 57
Figure 36: Skin Closure Devices, Belgium, Average Price ($), Forecast,
2007-2012 58
Figure 37: Wound Closure Devices, Belgium, Distribution Share
(%), 2006 59
Figure 38: Wound Closure Devices, Belgium, Company Share (%),
2006 60
Figure 39: Ostomy, Belgium, Overall Revenues ($ mn), Historic,
2000-2007 61
Figure 40: Ostomy, Belgium, Overall Revenues ($ mn),
Forecast, 2007-2012 62
Figure 41: Ostomy, Belgium, Overall Volume (Units),
Historic, 2000-2007 63
Figure 42: Ostomy, Belgium, Overall Volume (Units),
Forecast, 2007-2012 64
Figure 43: Ostomy, Belgium, Average Price ($),
Historic, 2000-2007 65
Figure 44: Ostomy, Belgium, Average Price ($),
Forecast, 2007-2012 66
Figure 45: Ostomy, Belgium, Company Share (%), 2006
68
Figure 46: Advanced Wound Management, Belgium, Overall Revenues ($ mn),
Historic, 2000-2007 69
Figure 47: Advanced Wound Management, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 70
Figure 48: Advanced Wound
Management, Belgium, Overall Volume (Units), Historic, 2000-2007 71
Figure
49: Advanced Wound Management, Belgium, Overall Volume (Units), Forecast,
2007-2012 72
Figure 50: Advanced Wound Management, Belgium, Average Price
($), Historic, 2000-2007 73
Figure 51: Advanced Wound Management, Belgium,
Average Price ($), Forecast, 2007-2012 74
Figure 52: Advanced Wound
Management, Belgium, Distribution Share (%), 2006 75
Figure 53: Advanced
Wound Management, Belgium, Company Share (%), 2006 76
Figure 54:
Traditional Wound Management, Belgium, Overall Revenues ($ mn), Historic,
2000-2007 77
Figure 55: Traditional Wound Management, Belgium, Overall
Revenues ($ mn), Forecast, 2007-2012 78
Figure 56: Traditional Wound
Management, Belgium, Overall Volume (Units), Historic, 2000-2007 79
Figure
57: Traditional Wound Management, Belgium, Overall Volume (Units), Forecast,
2007-2012 80
Figure 58: Traditional Wound Management, Belgium, Average
Price ($), Historic, 2000-2007 81
Figure 59: Traditional Wound Management,
Belgium, Average Price ($), Forecast, 2007-2012 82
Figure 60: Traditional
Wound Management, Belgium, Distribution Share (%), 2006 83
Figure 61:
Traditional Wound Management, Belgium, Company Share (%), 2006 84
Figure
62: Compression Therapy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
85
Figure 63: Compression Therapy, Belgium, Overall Revenues ($ mn),
Forecast, 2007-2012 86
Figure 64: Compression Therapy, Belgium, Overall
Volume (Units), Historic, 2000-2007 87
Figure 65: Compression Therapy,
Belgium, Overall Volume (Units), Forecast, 2007-2012 88
Figure 66:
Compression Therapy, Belgium, Average Price ($), Historic, 2000-2007 89
Figure 67: Compression Therapy, Belgium, Average Price ($), Forecast,
2007-2012 90
Figure 68: Compression Therapy, Belgium, Distribution Share
(%), 2006 91
Figure 69: Compression Therapy, Belgium, Company Share (%),
2006 92
Figure 70: Baxter International Inc., Value Chain Analysis
98
Figure 71: HARTMANN GROUP, Value Chain Analysis 136
Figure 72:
Coloplast A/S, Value Chain Analysis 152
Figure 73: Flowchart for
Classification of Non-invasive Devices in Belgium, 2007 197
Figure 74:
Flowchart for Classification of Invasive Devices in Belgium, 2007 198
Figure 75: Flowchart for Classification of Invasive Devices in Belgium, 2007
199
Figure 76: Flowchart for Classification of Invasive Devices in
Belgium, 2007 200
Figure 77: Flowchart for Classification of Invasive
Devices in Belgium, 2007 201
Figure 78: Flowchart for Classification of
Active Devices in Belgium, 2007 202
Figure 79: Flowchart for
Classification of Active Devices in Belgium, 2007 203
Figure 80: Flowchart
for Classification of Devices except Non-invasive, Invasive and Active Devices
in Belgium, 2007 204
Figure 81: Conformity Assessment of Class-I Medical
Devices in Belgium, 2007 205
Figure 82: Conformity Assessment of Class-IIa
Medical Devices in Belgium, 2007 206
Figure 83: Conformity Assessment of
Class-IIb Medical Devices in Belgium, 2007 207
Figure 84: Conformity
Assessment of Class-III Medical Devices in Belgium, 2007 208
Figure 85:
Global Markets Direct Methodology 212
